Genetic Analysis

Can a New Gene Test Prevent Fatal Lamotrigine Reactions?
Research & Development Can a New Gene Test Prevent Fatal Lamotrigine Reactions?

Although lamotrigine is a staple treatment for bipolar disorder and epilepsy, it triggers a dangerous systemic immune response in approximately one out of every thousand patients. Known as Stevens-Johnson Syndrome, this reaction causes severe skin detachment and organ damage. For years, doctors

How Do Genetics Influence Our Immune Response to COVID-19?
Tech & Innovation How Do Genetics Influence Our Immune Response to COVID-19?

The ability to detect regulatory signals in rare cell states provides a functional hypothesis-generating resource for prioritizing causal variants in large-scale genetic studies. Scientists have long observed that two individuals of similar age and health can experience radically different outcomes

How Is AstraZeneca Redefining the Future of Oncology?
Research & Development How Is AstraZeneca Redefining the Future of Oncology?

The synthesis of combination therapies and early detection creates a feedback loop that amplifies the effectiveness of modern cancer treatment protocols. This paradigm shift means oncologists no longer view cancer as a static entity confined to a single organ like the lung or breast. Instead, they

New R Package Geneslator Unifies Genomic Data Mapping
Tech & Innovation New R Package Geneslator Unifies Genomic Data Mapping

Discrepancies in gene nomenclature often force clinicians and computational biologists to struggle with different identifiers for the exact same biological sequence. In the high-stakes environment of 2026, where personalized medicine depends on granular genomic insights, this fragmentation

New Study Redefines Rare Genetic Disorder XLID93 in Females
Tech & Innovation New Study Redefines Rare Genetic Disorder XLID93 in Females

A 15-month-old girl with a rare genetic deletion of ten exons in the BRWD3 gene is challenging the long-held belief that XLID93 primarily manifests in males. Historically, X-linked intellectual developmental disorder-93 was viewed through a narrow lens that largely excluded female patients from the

How Is Aprea Therapeutics Reshaping Oncology Trial Design?
Research & Development How Is Aprea Therapeutics Reshaping Oncology Trial Design?

Next-generation sequencing has evolved into a standard care path at major cancer centers, allowing biotechnology firms like Aprea to identify patients with actionable mutations without the burden of expensive screening costs. This shift represents a fundamental departure from the historical

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later